Patents for A61P 23 - Anaesthetics (4,141)
07/2011
07/20/2011EP2345635A1 Amino acid derivative
07/20/2011EP2345427A1 Fluoran complex
07/14/2011US20110172580 Wound care dressing
07/14/2011US20110171311 Stable hydrogel compositions including additives
07/14/2011US20110171285 Design of Fibrinogen and Fibrinogen Derived Products with Reduced Bacterial Binding by Using Modified Sequences of Fibrinogen Chains
07/14/2011US20110171272 Urological medical devices for release of prostatically beneficial therapeutic agents
07/13/2011CN102119980A Chinese medicinal Hindu datura flower-manchurian wildginger compound skin surface infiltration anesthetic
07/12/2011CA2441744C Formulations containing propofol and a sulfoalkyl ether cyclodextrin
07/07/2011WO2011079807A1 Dipropofol pyrophosphate dihydrogen ester and pharmaceutically acceptable salt, preparation process and application thereof
07/07/2011US20110166181 Guanidine compounds as anesthetics and for treatment of nervous system disorders
07/07/2011US20110165063 Il-1 binding proteins
06/2011
06/30/2011US20110159104 Microemulsion
06/30/2011US20110159078 Volatile Anesthetic Compositions and Methods of Use
06/30/2011US20110158909 Cationic Contrast Agents and Methods of Use Thereof
06/29/2011EP2338448A2 Anti-inflammatory and antimicrobial uses for bioactive glass
06/23/2011WO2011074695A1 Shivering suppressor
06/23/2011WO2011074567A1 Transdermal preparation containing basic anti-inflammatory agent
06/23/2011WO2011074566A1 Felbinac-containing transdermal absorption preparation
06/23/2011US20110152216 Anaesthetic composition
06/23/2011CA2784133A1 Felbinac-containing transdermally absorbable preparation
06/23/2011CA2783569A1 Transdermally absorbable preparation containing basic anti-inflammatory analgesic
06/22/2011CN102100799A Anodynia disinfecting alcohol for injection
06/21/2011US7964644 Use of neurotoxic substances for the production of a means for the treatment of joint paint and method for application of said means
06/16/2011US20110142940 Analgesic Apatitic Calcium-Phosphate Cement
06/15/2011EP2332525A1 Pharmaceutical composition comprising propofol
06/14/2011CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain
06/08/2011CN102085185A Formula and preparation method of novel propofol fat emulsion preparation causing no pain and low injection stimulation
06/02/2011US20110129422 Viscous Terpolymers as Drug Delivery Platform
06/01/2011DE202010007433U1 Gel, insbesondere Gleitgel Gel, especially Lube
06/01/2011CN102083804A 5-phenyl-isoxazole-3-carboxamides modulating HSP90 with antitumoral activities
06/01/2011CN102078290A Method for preparing carbonate lidocaine injection
06/01/2011CN102078288A Pediatric anesthesia induction oral administration formulation and preparation method thereof
06/01/2011CN101658524B Compound anesthetic for dogs
05/2011
05/26/2011WO2011061469A1 Indazole derivatives and their use for blockading voltage dependent sodium channels
05/26/2011WO2011061332A1 Pharmaceutical composition comprising propofol
05/26/2011US20110124685 Anesthetic Compounds
05/26/2011CA2776855A1 Pharmaceutical composition comprising propofol
05/25/2011EP2324019A1 A crystalline form of 4-(5-{(ir)-1-[5- (3-chlorophenyl) isoxazol-3-yl]ethoxy}-4-methyl-4h-1,2,4-triazol-3-yl) pyridine
05/25/2011EP2323658A1 A new crystalline form of 4-(5-{ (ir)-1-[5-(3- chlorophenyl) isoxazol-3-yl]ethoxy}-4-methyl-4h-l, 2, 4-triazol-3-yl) pyridine
05/24/2011CA2453901C Substituted 4-aminocyclohexanols
05/24/2011CA2421562C A method of producing analgesia using sodium channel blocking compounds such as tetrodotoxin, saxitoxin and derivatives thereof
05/19/2011WO2011059388A1 Oxazolo[4,5-c]pyridine substituted pyrazine
05/19/2011WO2011057387A1 Nitric oxide amino acid esters for the treatment of chronic pain
05/19/2011US20110118256 Imidazo [1,2-a] pyridin-3-yl-acetic acid hydrazides, processes, uses and compositions
05/19/2011US20110117187 Topical compositions and methods for epithelial-related conditions
05/19/2011US20110117008 Use of avicins to deliver therapeutic and diagnostic agents
05/18/2011CN102058721A Sterilization alcohol for painless injection
05/18/2011CN102058523A Procaine injection
05/17/2011US7943643 Aryl substituted pyridines and the use thereof
05/17/2011US7943173 Pharmaceutical combinations of oxycodone and naloxone
05/17/2011US7942147 Aerosol forming device for use in inhalation therapy
05/17/2011CA2423358C Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/17/2011CA2401385C Protein matrix materials, devices and methods of making and using thereof
05/17/2011CA2376339C Morphine sulphate microgranules, method for preparing same and compositions containing same
05/12/2011US20110112194 Medicaments Containing Pantothenic Acid
05/12/2011US20110112189 Methods of treating pains associated with neuroma, nerve entrapment, and other conditions
05/11/2011EP2319574A2 Drug delivery system for conscious sedation
05/11/2011CN102050815A Dabigatran ester derivatives as prodrug
05/11/2011CN102050814A Ester derivatives of dabigatran
05/10/2011US7939689 Short-acting sedative hypnotic agents for anesthesia and sedation
05/10/2011US7939670 Nociceptin analogs
05/05/2011US20110104219 Denture care composition
05/04/2011CN201814877U Compound lidocaine patch
05/04/2011CN102046607A Etomidate analogues with improved pharmacokinetic and pharmacodynamic properties
05/04/2011CN102041175A Method for extracting total volatile oil and total alkaloids from zanthoxylum echinocarpum
05/04/2011CN102040601A 1-N-(1-azabicyalo(2,2,2) octane ether compound and application thereof
05/04/2011CN102040600A Substituted 1-azabicyclo (2, 2, 2) octane quaternary ammonium salt and use thereof
05/04/2011CN102040599A Pharmaceutical application of bicyclo-(2,2,2) octane pentenyl ester
05/04/2011CN102040598A Pharmacy application of 1-aza-bicyclo (2, 2, 2) octane amyl
05/04/2011CN102038953A Composite for local anesthesia before ophthalmologic operation and preparation method and application thereof
05/04/2011CN102038651A Ropivacaine mesylate freeze-dried powder injection
05/03/2011CA2400778C Aryl substituted pyrazoles, triazoles and tetrazoles, and the use thereof
04/2011
04/28/2011US20110097384 Transdermal drug delivery device including an occlusive backing
04/26/2011CA2446461C Substituted cyclohexane-1,4-diamine derivatives
04/21/2011US20110091577 Drug release coatings on calcuim phosphate and uses thereof
04/21/2011US20110091544 Compositions and Methods for Mild Sedation, Anxiolysis and Analgesia in the Procedural Setting
04/21/2011US20110091508 Oligofluorinated cross-linked polymers and uses thereof
04/20/2011EP2311824A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics
04/20/2011EP2310377A1 5-phenyl-isoxazole-3-carboxamides modulating hsp90 with antitumoral activities
04/20/2011CN102020574A diisopropylphenyl gamma-aminobutyrate derivatives and preparation methods thereof
04/20/2011CN101411685B Intravenous anesthetics 2,6-diisopropyl phenol microemulsion composition and method of making the same
04/19/2011US7927622 Methods of transnasal transport/immunization with highly adaptable carriers
04/14/2011US20110086922 Sensory-specific local anesthesia and prolonged duration local anesthesia
04/14/2011US20110086109 Low ether compositions and delivery apparatus
04/13/2011EP2308470A1 Sustained-release liposomal anesthetic compositions
04/13/2011CN101454007B Adhesive
04/13/2011CN101365433B Iontophoresis preparation
04/13/2011CN101062019B Lappaconitine hydrobromide transparent patch and the preparing method thereof
04/07/2011US20110082211 Method for treating tinnitus aureum
04/07/2011US20110081422 Prolonged release of local anesthetics using microparticles and surgery applications
04/06/2011CN102002050A Bisbenzylisoquinoline derivative and preparation and application thereof
04/06/2011CN102000077A Preparation for injection with mepivacaine isomers
04/06/2011CN102000049A Injection preparation containing etidocaine isomer
04/05/2011CA2425638C Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
03/2011
03/30/2011EP1392381B1 An aerosol forming device for use in inhalation therapy
03/29/2011US7915317 substantially free of glyceryl esters of medium or long chain fatty acids; propofol red blood cell-blood plasma partition coefficient, Kp, for the composition is at least about twice the Kp obtained upon administration of a conventional propofol emulsion under the same delivery conditions
03/29/2011US7915258 Substituted 2,5-dihydro-3H-pyrazolo[4,3-C]pyridazin-3-one derivatives, preparation thereof and therapeutic use of the same
03/29/2011US7915226 Methods of suppressing microglial activation
03/24/2011US20110071203 Transmucosal veterinary composition comprising detomidine
03/24/2011US20110071184 Manufacture of tablet in a die utilizing radiofrequency energy and meltable binder
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 42